Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.

Cu-Uvin S, DeLong AK, Venkatesh KK, Hogan JW, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM.

AIDS. 2010 Oct 23;24(16):2489-97. doi: 10.1097/QAD.0b013e32833e5043.

PMID:
20736815
2.

Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.

Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S.

J Womens Health (Larchmt). 2013 Apr;22(4):330-8. doi: 10.1089/jwh.2012.3849. Epub 2013 Mar 26.

3.

Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.

Homans J, Christensen S, Stiller T, Wang CH, Mack W, Anastos K, Minkoff H, Young M, Greenblatt R, Cohen M, Strickler H, Karim R, Spencer LY, Operskalski E, Frederick T, Kovacs A.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):99-110. doi: 10.1097/QAI.0b013e31824aeaaa. Erratum in: J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e106.

4.

Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.

Fiore JR, Suligoi B, Saracino A, Di Stefano M, Bugarini R, Lepera A, Favia A, Monno L, Angarano G, Pastore G.

AIDS. 2003 Oct 17;17(15):2169-76.

PMID:
14523273
5.

Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.

Ondoa P, Gautam R, Rusine J, Lutter R, Jurriaans S, Kootstra N, Karita E, van de Wijgert J.

PLoS One. 2015 May 26;10(5):e0127201. doi: 10.1371/journal.pone.0127201. eCollection 2015.

6.

Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood.

García-Bujalance S, Ruiz G, De Guevara CL, Peña JM, Bates I, Vázquez JJ, Gutiérrez A.

Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):111-5. Epub 2004 Jan 20.

PMID:
14735402
7.

Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.

Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda N, van de Perre P, Mayaud P; Yerelon Study Group..

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):237-45. doi: 10.1097/QAI.0000000000000049.

8.

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.

Delany S, Mlaba N, Clayton T, Akpomiemie G, Capovilla A, Legoff J, Belec L, Stevens W, Rees H, Mayaud P.

AIDS. 2009 Feb 20;23(4):461-9. doi: 10.1097/QAD.0b013e32831db217.

9.

Genital HIV shedding in women.

Iversen AK.

AIDS Patient Care STDS. 1999 Dec;13(12):695-701.

PMID:
10743532
10.

Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso.

Nagot N, Ouedraogo A, Weiss HA, Konate I, Sanon A, Defer MC, Sawadogo A, Andonaba JB, Vallo R, Becquart P, Segondy M, Mayaud P, Van de Perre P; Yerelon Study Group..

Sex Transm Infect. 2008 Jun;84(3):167-70. Epub 2007 Nov 30.

PMID:
18055582
11.

Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy.

Woo VG, Liegler T, Cohen CR, Sawaya GF, Smith-McCune K, Bukusi EA, Huchko MJ.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):1000-5. doi: 10.1089/AID.2012.0341. Epub 2013 May 15.

12.

HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.

Prazuck T, Chaillon A, Avettand-Fènoël V, Caplan AL, Sayang C, Guigon A, Niang M, Barin F, Rouzioux C, Hocqueloux L.

PLoS One. 2013 Aug 21;8(8):e69686. doi: 10.1371/journal.pone.0069686. eCollection 2013.

13.

Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe.

Cowan FF, Pascoe SJ, Barlow KL, Langhaug LF, Jaffar S, Hargrove JW, Robinson NJ, Latif AS, Bassett MT, Wilson D, Brown DW, Hayes RJ.

AIDS. 2006 Jan 9;20(2):261-7.

PMID:
16511420
14.

Genital tract leukocytes and shedding of genital HIV type 1 RNA.

Anderson BL, Wang CC, Delong AK, Liu T, Kojic EM, Kurpewski J, Ingersoll J, Mayer K, Caliendo AM, Cu-Uvin S.

Clin Infect Dis. 2008 Nov 1;47(9):1216-21. doi: 10.1086/592303.

15.

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.

Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC.

AIDS. 2000 Mar 10;14(4):415-21.

PMID:
10770544
16.

Correlates of human immunodeficiency virus cervicovaginal shedding among postmenopausal and fertile-aged women.

Melo KC, Melo MR, Ricci BV, Segurado AC.

Menopause. 2012 Feb;19(2):150-6. doi: 10.1097/gme.0b013e3182288b0e.

PMID:
21983010
17.

Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts.

Coleman JS, Hitti J, Bukusi EA, Mwachari C, Muliro A, Nguti R, Gausman R, Jensen S, Patton D, Lockhart D, Coombs R, Cohen CR.

AIDS. 2007 Mar 30;21(6):755-9.

PMID:
17413697
18.

Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.

Graham SM, Jalalian-Lechak Z, Shafi J, Chohan V, Deya RW, Jaoko W, Mandaliya KN, Peshu NM, Overbaugh J, McClelland RS.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):511-8. doi: 10.1097/QAI.0b013e31825bd703.

19.

Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania.

Todd J, Riedner G, Maboko L, Hoelscher M, Weiss HA, Lyamuya E, Mabey D, Rusizoka M, Belec L, Hayes R.

PLoS One. 2013;8(3):e59037. doi: 10.1371/journal.pone.0059037. Epub 2013 Mar 13.

20.

Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.

Herold BC, Keller MJ, Shi Q, Hoover DR, Carpenter CA, Huber A, Parikh UM, Agnew KJ, Minkoff H, Colie C, Nowicki MJ, DʼSouza G, Watts DH, Anastos K.

J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):485-93. doi: 10.1097/QAI.0b013e3182961cfc.

Supplemental Content

Support Center